Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Ilika Plc LSE:IKA London Ordinary Share GB00B608Z994 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 58.50 57.00 60.00 58.50 58.00 58.50 833 08:00:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Alternative Energy 0.5 -8.1 -4.7 - 92

Ilika Share Discussion Threads

Showing 4376 to 4396 of 5375 messages
Chat Pages: Latest  179  178  177  176  175  174  173  172  171  170  169  168  Older
DateSubjectAuthorDiscuss
25/1/2021
20:01
$3.995 +0.315 (+8.56%) Jan 25, 2021 14:46
thefartingcommie
25/1/2021
19:04
Heading to $4 in US. Am surprised given all the negative stuff around QS. Management must be thinking how to accelerate plans
robertspc1
25/1/2021
17:24
.....blue sky ahead then! Always great to close at an ATH!
adorling
25/1/2021
15:16
Threatening another spike upwards.
this_is_me
25/1/2021
06:52
Yes onwards and upwards
nw99
25/1/2021
06:51
Very impressive
nw99
24/1/2021
23:28
Old article rehashed
shstt1
24/1/2021
22:33
Further to Roberts post.. The Sunday Times 24th January 2021 Britain must build battery gigafactories to save electric car dreams. Giant gigafactories for batteries are key to the future of the car industry. We have until 2026 to build a supply chain or face crippling tariffs, Jaguar Land Rover’s award- winning I-Pace electric car hit a roadblock last year that typified the challenges facing the automotive industry: their supply of batteries ran out. The component crisis, which forced JLR to halt manufacturing of its Tesla rival for a week, was not caused by problems at its British factories or suppliers. Production stopped at the I-Pace plant in Austria after South Korea’s LG Chem failed to fulfil its contract to supply batteries from its gigafactory in Poland. The Jaguar stoppage underlined the global scale of the electric battery race — a race in which Britain is currently a distinct laggard. Companies such as ilika harbour huge potential if they achieve their planned Next gen battery manufacturing roll out.
phil2003
24/1/2021
12:23
Ilika gets a good mention in the Sunday Times today (p4 Business). "Our best chance...is with the next generation of battery technology" etc. "It will mean turbocharging British companies such as ... Ilika which is making solid state batteries". Expect multimillion grant soon!
robertspc1
22/1/2021
17:33
Blue sky territory.
shammytime
22/1/2021
16:54
Chart break out
nw99
22/1/2021
12:00
*IF* we close @ 250p level today.. you know what happens next week, right? RogK gets super angry / priced out forever at we head towards next target, 315p LOL
phil2003
21/1/2021
16:15
That will teach me! Post 3697 was closer to the mark than my fruitless attempt to engage with you. So what you have is “They had no choice” X 2, babbling like a baby. You managed to miss quote the company, provide zero rationale or evidence to support your claim & fill me with reject. Watch out people, Rogk’s back in the game :)
tp5588
21/1/2021
14:57
Hello.. Yeah.. Stick an iceberg in.. Yeah.. Get as many IKA as you can for £2.40 yeah Yeah.. OK (The conversation driving today’s chart pattern)
phil2003
21/1/2021
13:43
Rogk, it’s no fun if you don’t play. Pls don’t leave town. On a (more) serious note; they did mess up the whole licencing thing, but it is old news. With hindsight, the company going straight from R&D to licencing was overly ambitious. The initial £1m licence fee plus what we now know would be £4m equipment/installation plus IKA consultancy etc seems to have been too bigger cost/risk for the 3rd parties to bear. Look at Murata & CPX. IKA adapted. Create and demonstrate a fully-fledged manufacturing facility with definitive costs, equipment sourcing & efficient operation (tba). I would imagine individual customer orders in medtech (e.g) would be for what 50-200 units to create prototypes for testing & FDA submission. Licencing isn’t suitable for that. IKA’s new fab is, where they supply relatively small quantities to a lot of customers. The cost to each customer is relatively negligible but IKA enjoys high margins & relatively high output. (over use of "relatively"?) Why the licencing model hasn’t worked yet is probably cost, but it might have been related to the scope of ip and/or something else. The fab is a bridge that was needed. Common-sense and the directors (mentioning letters of intent) suggests that more substantial orders are in motion/will be forthcoming. Expansion in capacity etc then leads to licencing. These are some of my thoughts re the whole licencing thing (circa 2014-2018). How factual they are, I don’t know & to a large extent it doesn’t matter. It’s old news.
tp5588
21/1/2021
12:37
So where’s he living now? :) “I don't need to ask because I know the answers already” so the point of asking the question here is…..?
tp5588
21/1/2021
11:50
Rogk, Ouch!! Someone should at least cuddle you afterwards…. The Q & A session just 7 days ago, advertised well in advance….. If you really wanted to know anything you would have asked. Wouldn't you?
tp5588
21/1/2021
11:42
Rogk, You need to get some help.
jimmyann
21/1/2021
11:39
Nearly back down to your £1.20 sell out point Rogk, LOL Flag pattern continues prior to next leg up
phil2003
21/1/2021
11:23
Rogk, The rubbish you write is unbelievable!!.Absolute twaddle! Move on. We know investing in Ilika is not for you.
jimmyann
21/1/2021
11:06
Stammering donkey, dyofr
shstt1
Chat Pages: Latest  179  178  177  176  175  174  173  172  171  170  169  168  Older
ADVFN Advertorial
Your Recent History
LSE
IKA
Ilika
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220926 07:19:11